Advanced Biomed Inc. Common Stock (ADVB) — Financial Flexibility Index

Latest as of December 2025: -0.01x

Advanced Biomed Inc. Common Stock (ADVB) has a Financial Flexibility Index of -0.01x as of December 2025. Free cash flow of $-15.39K (operating CF $-15.81K minus capex $419.00) represents 0% of total liabilities ($1.37 Million). Also explore ADVB net assets growth trend to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-0.01x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-15.39K
Operating CF − Capex

Total Liabilities

$1.37 Million
USD

Capital Expenditures

$419.00
USD

Advanced Biomed Inc. Common Stock Financial Flexibility Index (2021–2025)

Historical Financial Flexibility Index trend for Advanced Biomed Inc. Common Stock across 5 annual periods. See net asset quality index of Advanced Biomed Inc. Common Stock to measure how much of total assets are equity-financed.

Annual Financial Flexibility Index for Advanced Biomed Inc. Common Stock (2021–2025)

Year-by-year free cash flow to debt coverage for Advanced Biomed Inc. Common Stock. For the full company profile including market capitalisation, see ADVB market cap overview.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 0.00x $-180.48K $-181.46K $3.03 Billion ▲ +100.0%
2024 -0.73x $-2.05 Million $-2.13 Million $2.80 Million ▲ +12.1%
2023 -0.84x $-2.75 Million $-2.96 Million $3.29 Million ▼ -571.5%
2022 0.18x $570.68K $-741.45K $3.22 Million ▲ +101.2%
2021 -14.89x $-448.53K $-473.98K $30.13K
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities